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Background: Since rotavirus is one of the leading pathogens that cause severe gastroenteritis and represents a
serious threat to human and animal health, researchers have been searching for cheap, safe, and effective
anti-rotaviral drugs. There is a widespread of interest in using natural products as antiviral agents, and among them,
licorice derived from Glycyrrhiza spp. has exerted antiviral properties against several viruses. In this study,
anti-rotaviral efficacy of Glycyrrhiza uralensis extract (GUE) as an effective and cheaper remedy without side-effects
was evaluated in colostrums-deprived piglets after induction of rotavirus diarrhea.
Methods: Colostrums-deprived piglets were inoculated with porcine rotavirus K85 (G5P[7]) strain. On the onset of
diarrhea, piglets were treated with different concentration of GUE. To evaluate the antiviral efficacy of GUE, fecal
consistency score, fecal virus shedding and histological changes of the small intestine, mRNA expression levels of
inflammation-related cytokines (IL8, IL10, IFN-β, IFN-γ and TNF-α), signaling molecules (p38 and JNK), and
transcription factor (NFκB) in the small intestine and spleen were determined.
Results: Among the dosages (100-400 mg/ml) administrated to animals, 400 mg/ml of GUE cured diarrhea, and
markedly improved small intestinal lesion score and fecal virus shedding. mRNA expression levels of
inflammation-related cytokines (IL8, IL10, IFN-β, IFN-γ and TNF-α), signaling molecules (p38 and JNK), and
transcription factor (NFκB) in the small intestine and spleen were markedly increased in animals with RVA-induced
diarrhea, but dose- dependently decreased in GUE treated animals after RVA-induced diarrhea.
Conclusions: GUE cures rotaviral enteritis by coordinating antiviral and anti-inflammatory effects. Therapy of this
herbal medicine can be a viable medication for curing rotaviral enteritis in animals and humans.
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Group A rotaviruses (RVAs) are the leading cause of
gastroenteritis, malnutrition, and diarrhea in young chil-
dren and animals [1]. In humans, RVAs are estimated to
cause 453,000 deaths per year in children below 5 years
of age, mostly in developing countries [2]. Deaths from
RVA infection are most prevalent in developing nations,
where patients may not always receive adequate medical
attention quickly enough [3].* Correspondence: wslee@kribb.re.kr; choko@chonnam.ac.kr
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reproduction in any medium, provided the orCurrently, there are two commercially available vac-
cines in the market. RotaTeq (Merck) is a pentavalent
human-bovine reassortant live attenuated oral vaccine,
while Rotarix (GlaxoSmithKline) is a live-attenuated
human RVA vaccine [4]. These vaccines appear to be
promising in preventing RVA diarrhea. However, each is
only effective against a particular strain of the virus, the
high cost of production, and has a high probability of
manifesting side effects in particular with vaccine-
derived transmission of RVAs in immunocompromised
patients [5].
Synthetic compounds, such as ribavirin, 3-deazagua-
nine, cimetidine, famotidine, dipyridamole, nifedipine,
and isoprinosine, have been shown to inhibit RVALtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pounds, natural compounds, such as Diotahedral
smecta, tea and pine seed shell extract, cacao pigment,
Sophora flavescens extract, and Stevia rebaudiana have
been identified as ideal candidates for antirotaviral drugs
in developing countries because they are effective and
cheaper with minimal or without toxicity and side-
effects [9-11]. Also noted were compounds found in
human milk and soy infant formulation [12-14] that
were effective in inhibiting rotavirus infection. Potential
components found in high levels in soy-based infant for-
mulation were isoflavones [14]. In vitro study revealed
that genistin and mixtures of isoflavones can inhibit
rotavirus infection by modulating virus attachment and
post-binding step [14]. High levels of antiviral activity
were found to be related with mucin found in the
human milk [12]. Both in vitro and in vivo studies
showed that variation in milk mucin glycoproteins may
be correlated with different levels of protection against
infection with gastrointestinal pathogens [12]. Lactad-
herin, a mucin-associated glycoprotein was also found to
specifically inhibit rotavirus replication both in vitro and
in vivo [13].
Licorice, dried and processed Glycyrrhiza radix, has
been used for the treatment of peptic ulcer disease, con-
stipation, cough, and other diseases since antiquity
[15,16]. In addition, licorice extracts have generally been
recognized as safe and are used as flavoring and sweet-
ening agents for tobaccos, chewing gums, candies, tooth-
paste, and beverages [16]. The bioactive constitute of
licorice root are saponins, flavonoids, isoflavones, cou-
marins, stilbenoids, and some miscellaneous compounds
[15]. These compounds exert many useful pharmaco-
logical properties that include anti-cancer, anti-diabetic,
anti-inflammatory, anti-malaria, anti-bacterial, antioxi-
dant, and estrogenic activities [15,17]. The compounds
extracted from Glycyrrhiza species showed antiviral ac-
tivities via inhibiting virus absorption and replication
such as influenza virus, severe acute respiratory syn-
drome (SARS) coronavirus, hepatitis A-C viruses (HAV-
HCV), Epstein Barr virus, human immunodeficiency
virus (HIV), and Japanese encephalitis virus [16,18].
Moreover, these compounds are known to modulate
virus-induced inflammatory response [17,19]. In our pre-
vious study [20], polyphenol compounds from the roots
of Glycyrrhiza uralensis (G. uralensis) exerted in vitro
anti-RVA activity by inhibiting both viral absorption and
viral replication. Another in vitro study also suggests
that 18β-glycyrrhetinic acid, the aglycone product of gly-
cyrrhizin hydrolysis can inhibit rotavirus entry into the
cells [21]. However, there is little evidence whether this
compound inhibit RVA infection in the animal models.
The aim of this study is to investigate the influence of
the G. uralensis extract (GUE) on RVA-induceddiarrhea, fecal RVA shedding, RVA-induced histological
lesion changes, RVA-induced cytokine expression, and
RVA-induced cellular signaling events in colostrums-
deprived piglets. The results of this study suggest that
the GUE cures rotaviral enteritis by coordinating anti-
viral and anti-inflammatory effects.
Results
Influence of GUE on RVA-induced diarrhea
To determine the effective dose of GUE for RVA-
induced diarrhea, colostrums-deprived piglets were or-
ally given with 100 mg/ml, 200 mg/ml, or 400 mg/ml.
Control piglets with mock-inoculation and mock-
treatment did not show diarrhea throughout the experi-
mental period, whereas piglets inoculated with RVA
alone showed diarrhea at day post-inoculation (DPI) 2
and diarrhea persisted to the termination of the experi-
ment. All piglets treated with 100 mg/ml and 200 mg/ml
continuously showed diarrhea until the termination of
the experiment (Figure 1). The piglets treated with 400
mg/ml GUE exhibited decreased fecal consistency score
at DPI 7, and diarrhea was cured at DPI 8 or 9
(Figure 1).
Influence of GUE on fecal RVA shedding
To evaluate the influence of GUE on the fecal RVA
shedding, the viral RNA copy numbers in the fecal sam-
ples were individually quantified, enabling the compari-
son between the mocked-treated and treated groups.
Piglets treated with 100 mg/ml and 200 mg/ml GUE did
not show any improvement of fecal virus shedding,
which remained high until the termination of the experi-
ment in comparison with the virus inoculated and
mocked-treated piglets (Figure 2). Piglets treated with
400 mg/ml revealed a rapid decrease of viral copy num-
bers in the fecal samples, compared with virus inocu-
lated and mocked-treated group (Figure 2).
Influence of GUE on RVA-induced histological lesion
changes in the small intestine
To determine the influence of GUE on RVA-induced
histological lesion changes in the small intestine, intes-
tinal samples were collected from all experimental pig-
lets. The histological changes in the small intestines
sampled from each experimental group are summarized
in Table 1. The mock-inoculated group showed long and
slender villi with short crypts of the small intestine
(Figure 3A-C), while virus-inoculated piglets had marked
villi atrophy and crypt hyperplasia (Figure 3D-F). Com-
pared to severe histological changes of small intestine
from piglets inoculated with RVA alone, piglets given
100 mg/ml or 200 mg/ml GUE exhibited gradual im-
provement of lesion changes (Figure 3G-L). Remarkably,
piglets receiving 400 mg/ml of GUE showed marked
Figure 1 Duration and fecal consistency score of colostrums-deprived piglets treated with the Glycyrrhiza uralensis extract (GUE) after
induction of rotaviral diarrhea. Values are mean ± S.D. (n=3) (*p<0.05).
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O). Like the control group, piglets treated with various
concentrations of GUE alone had normal villi and crypts
in the small intestine (Figure 3P-R).Influence of GUE on activation of p38, JNK, and NFκB
Relative mRNA expression using specific primer pairs to
p38, JNK, or NF-κB was quantified by real-time PCR
assay. Samples of the duodenum, jejunum, ileum and
splenocytes were collected from each group. mRNA
expressions levels of p38, JNK, and NF-κB were com-
pared with that of β-actin. The mock-treated piglets
after RVA diarrhea had higher mRNA expression levels
of p38, JNK, and NF-κB in the duodenum, jejunum,
ileum, and splenocytes, compared to the normal piglets
(Figure 4A-C). Dose-dependently, GUE treatment
reduced these expression levels in the duodenum, je-
junum, ileum, and splenocytes, and significant down-
regulation was observed in the 400 mg/ml GUE treat-
ment group (Figure 4A-C). A highly significant linear ef-
fect of GUE in reducing the mRNA expression of p38,JNK, and NF-kB was observed in the duodenum, je-
junum, ileum, and splenocytes using a polynomial or-
thogonal contrast (data not shown). Like the control
group, the piglets treated with GUE alone, regardless of
its concentration (100-400 mg/ml), showed the basal
levels of p38, JNK, and NF-κB expression in the duode-
num, jejunum, ileum and splenocytes (Figure 4A-C).Influence of GUE on mRNA expression levels of IL8, IL10,
IFN-β, IFN-γ and TNF-α
Real-time RT-PCR assays with primer pairs specific to
IL8, IL10, IFN-β, IFN-γ or TNF-α were performed with
duodenum, jejunum, ileum and splenocytes sampled
from each group. The relative mRNA expression levels
were compared with that of β-actin. The normal or
mock-inoculated and GUE-treated groups (100-400 mg/
ml) showed the basal levels of IL8, IL10, IFN-β, IFN-γ,
and TNF-α mRNA expression in the duodenum, je-
junum, ileum, and splenocytes (Figure 5A-E). However,
the mock-treated piglets after RVA diarrhea had higher
mRNA levels of IL8, IL10, IFN-β, IFN-γ, and TNF-α,
Figure 2 Quantification of viral RNA copy numbers by SYBR Green real-time RT-PCR in the fecal samples of mock-treated and
Glycyrrhiza uralensis extract (GUE). Values are mean ± S.D. (n=3). The asterisk indicate significant differences (*p<0.05; **p<0.01) compared to
the positive control.
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treated groups after RVA diarrhea showed a gradual de-
crease of these cytokines in a dose-dependent manner in
these tissues (Figure 5A-E). Further analysis of the or-
thogonal contrasts showed linearity of data for reducing
the mRNA expression of IL8, IL10, IFN- β, IFN- γ, and
TNF- α in conjunction with the increasing amount of
GUE in duodenum, jejunum, ileum, and splenocytes




Mock-inoculated & mock-treated 0 ± 0.00
400 mg GUE treated 0 ± 0.00
Virus-inoculated + mock-treated 3.82 ± 0.06
Virus-inoculated + 100 mg GUE treated 3.18 ± 0.03***
Virus-inoculated + 200 mg GUE treated 2.91 ± 0.01***
Virus-inoculated + 400 mg GUE treated 1.58 ± 0.08***
a The intestinal changes are scored according to the average villi/crypt (V/C) ratio p
C ratio, 0 = normal; (V/C ≥6:1), 1 = mild; (V/C = 5.0 – 5.9:1), 2 = moderate; (V/C = 4.0
desquamation grade, 0 = normal (no desquamation), 1 = mild (a few desquamated
epithelium), 3 = marked (desquamation of lower villous epithelium), 4 = severe (de
b Values are mean ± S.D. (n=3). The asterisk indicate significant differences (*p<0.05Discussion
In spite of the intensive efforts to prevent and control
RVA infections, it is still a major global problem with
high morbidity and mortality particularly in developing
countries [9]. Therefore, inexpensive and effective nat-
ural compounds from food and herbal products are ideal
candidates for use as preventative and therapeutic drugs
against RVA diarrhea in developing countries. Previ-
ously, we demonstrated that polyphenol compoundshe small intestines sampled from each experimental
Lesion scorea, b
Jejunum Ileum
0 ± 0.00 0 ± 0.00
0 ± 0.00 0 ± 0.00
3.09 ± 0.05 2.95 ± 0.10
2.86 ± 0.30 2.80 ± 0.06
2.83 ± 0.01 2.77 ± 0.03*
1.54 ± 0.02*** 1.50 ± 0.05***
lus the grade of epithelial cell desquamation, which is measured as follows: V/
– 4.9:1), 3 = marked; (V/C = 3.0 – 3.9:1), 4 = severe; (V/C ≤3.0:1), and
cells of tip villous epithelium), 2 = moderate (desquamation of upper villous
squamation of crypt epithelium).
; *** p<0.001) compared to the positive control.
Figure 3 Histopathological changes of small intestine sampled from control and Glycyrrhiza uralensis extract (GUE) treated groups.
(A-C) Control piglet shows unaltered duodenum (A), jejunum (B) and ileum (C) with long and slender villi. (D-F) Piglet inoculated with RVA
displays severe villi atropy and crypt hyperplasia in the duodenum (D), jejunum (E) and ileum (F). (G-I) Piglet treated with 100 mg/ml GUE
exhibits slight improvement of lesion changes in the duodenum (G), jejunum (H) and ileum (I). (J-L) Piglet treated with 200 mg/ml GUE reveals
moderate improvement of lesion changes in the duodenum (J), jejunum (K) and ileum (L). (M-O) Piglet treated with 400 mg/ml GUE shows
markedly restored villi and crypt in the duodenum (M), jejunum (N) and ileum (O). (P-R) Piglet treated with 400 mg/ ml GUE shows unaltered
duodenum (P), jejunum (Q) and ileum (R) with long and slender villi. Hematoxyline and eosin stain. Bars = 200 μm.
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Figure 4 Influence of Glycyrrhiza uralensis extract (GUE) on rotavirus-induced expression of p38, JNK, and NF-κB in colostrums-
deprived piglets. Comparison of mRNA expression levels of p38, JNK, and NF-κB with those of β-actin in each experimental group was
determined by SYBR Green Real-time RT-PCR. Values are means ± S.D. (n=3) (*p<0.05).
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RVA activity [20]. Recently, 18beta-glycyrrhetinic acid is
known to inhibit rotavirus replication in culture [21].
These results prompted us to presently evaluate anti-
RVA activity of GUE in an animal model.
A number of studies have been conducted using neo-
natal pig model in studying vaccines, passive antibody
(Ab) treatments and development of immune response
to rotavirus infection [22]. Moreover, the similarity in
the gastrointestinal physiology and immune system of
piglets and human infants [22] makes it a suitable ani-
mal model for testing the efficacy of antirotaviral drug
candidates. In the present study, colostrums-deprived
piglets obtained from sows by hysterectomy and main-
tained in isolator units were used as a RVA animalFigure 5 Influence of Glycyrrhiza uralensis extract (GUE) on rotavirus-
colostrums-deprived piglets. Comparison of mRNA expression levels of I
experimental group was determined by SYBR Green Real-time RT-PCR. Valumodel, and this model exactly showed diarrhea at DPI 2
after oral inoculation of a porcine RVA K85 strain. We
selected the porcine G5P[7] K85 strain for this study
since the genotype constellation of the porcine and
human rotaviruses was very similar, suggesting sharing
the same ancestor [23]. Among virus-inoculated and
GUE treated groups, GUE at a dose of 400 mg/ml
administered to the test animals completely cured RVA
diarrhea. The anti-RVA effects of GUE were also
demonstrated by a significant improvement of the in-
testinal lesion score and of the fecal virus shedding.
These results suggest that this herbal medicine may be a
potent medication for curing RVA diarrhea in humans
and animals. In recent studies, rotaviruses had been
detected in extraintestinal organs and in serum samplesinduced expression of IL8, IL10, IFN-β, IFN-γ, and TNF-α in
L8, IL10, IFN-β, IFN-γ, and TNF-α with those of β-actin in each
es are means ± S.D. (n=3) (*p<0.05).
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future study, therefore, the effect of GUE on these
points should be addressed.
Although the precise mechanisms of how the GUE
cured RVA diarrhea in the colostrums-deprived piglets
are unknown, diverse pathways may be participated. Of
particular interest is that polyphenol compounds isolated
from the roots of G. uralensis had inhibitory effects of
RVA activities in cultured cells through blocking viral
adsorption to cells and virus replication in the cells [20].
In the present in vivo study, GUE completely cured diar-
rhea and significantly improved fecal virus shedding and
histological lesion changes in the small intestine. Like
our in vitro data [20], polyphenol compounds in the
GUE may inhibit virus replication in the villous epithe-
lium of small intestine, where RVAs mainly replicate.
This inhibitory activity may result in marked reduction
of virus excretions from the infected cells into small in-
testinal lumen. Another interesting finding showed that
18β-glycyrrhetinic acid, a metabolite of glycyrrhizin
reduced the yields of infectious virus and viral protein
levels by interfering with rotavirus replication at a step
subsequent to virus entry [21]. Another possible in vivo
inhibitory mechanism is that polyphenol compounds in
the GUE may bind the sialic acid receptor of RVA on
the cell surface of the small intestinal villi [20]. Conse-
quently, viruses released from the infected cells could
not infect new epithelial cells of the small intestinal villi.
Taken together, the data indicate that all these compounds
in the GUE cure diarrhea by blocking RVA attachment
(polyphenol compounds), entry (18β-glycyrrhetinic acid)
and replication (polyphenol compounds) in the villous
epithelium.
RVA infection elevates proinflammatory cytokines,
such as IL1, IL8, and TNF- α, and later the Th1 cyto-
kines, such as IL2 and IFN-β, and the Th2 cytokines IL4,
and IL10 [25,26]. Activation of NFκB, p38, and JNK has
been associated with virus replication and virus-induced
pro-inflammatory gene expression [27,28]. However,
some rotavirus strains are known to down-regulate
NFκB activity through the functions of nonstructural
protein NSP1 [29]. Inflammatory responses, which are
the most important host defense mechanism against
pathogens, can be detrimental and are often more harm-
ful to the hosts than the inciting pathogens. In the
present experiment, RVA infection increased mRNA ex-
pression levels of IL-8, IL-10, IFN-β, IFN-γ and TNF- α
in the small intestine and spleen in piglets inoculated
with RVA alone, whereas GUE treatment down-
regulated the mRNA expression levels of these genes in
the piglets after the induction of RVA diarrhea as indi-
cated by polynomial orthogonal contrast. Moreover,
NFκB, p38, and JNK genes were inhibited in the GUE-
treated piglets after RVA diarrhea, but were activated inthe RVA-infected piglets without treatment. These data
suggested that GUE treatment modulates proinflamma-
tory reaction, leading alleviating intestinal lesions being
exacerbated by host inflammation.
It is known that glycyrrhizin down-regulates proin-
flammatory cytokines, and inhibits the activation of
NFκB, p38, and JNK genes in virus-infected cells
[27,30,31]. Notable, however, were reports that showed
18beta-glycyrrhetinic acid can induce NFκB activation
and generate IL-8 secretion in RVA-infected MA 104
cells [21,32]. In the present study, proinflammatory cyto-
kines, and its related transcription factor and signaling
molecules are inhibited in the GUE-treated piglets after
RVA diarrhea, but not in the RVA-inoculated piglets
without treatment. Although 18beta-glycyrrhetinic acid
can induce NFκB activation and generate IL-8 secretion
in vitro and possibly in vivo, in vivo inhibitory effects of
these proinflammatory reactions might be predominant
by glycyrrhizin and other compounds in the GUE as well
as viral nonstructural protein NSP1. The future studies
need to address which compound exerts inflammatory
or anti-inflammatory effects in animal models. We are
currently investigating the roles of several compounds in
the GUE in modulating the rotavirus infection in vivo.
In addition, the activation of NFκB, p38, and JNK
genes is constituents of redox-sensitive signaling path-
ways [33,34]. Therefore, anti-oxidants had been already
found to interfere with virus-induced pro-inflammatory
gene expression [27]. Since glycyrrhizin is known to
exert antioxidative effects [15], GUE may interfere with
RVA-induced reactive oxygen species formation and
then protect intestinal epithelial cells from reactive oxy-
gen species elicited by RVA infection.
In conclusion, we show in this report that GUE cure
RVA-induced diarrhea in colostrums-deprived piglets.
The anti-inflammatory and antiviral effects of GUE can
be attributed to the interaction of the different pharma-
cological active components of GUE. Since there are no
currently available anti-RVA drugs for human or animal
use, this anti-rotaviral drug candidate may complement
the arsenal of potential drugs for the treatment of RVA
enteritis, not only in animals but also in humans.Materials and methods
Cell and virus
Porcine K85 (G5[P7]) strain which was originally iso-
lated from fecal sample of a diarrheic piglet [35] was
cultured in fetal rhesus monkey TF-104 kidney cell (a
cloned derivative of MA-104 monkey kidney cells). Virus
titer was determined by cell culture immunofluorescence
assay with monoclonal antibody against the VP6 protein
of the porcine rotavirus strain OSU, and was expressed
as fluorescence focus units per milliliter (FFU/ml).
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Dried roots of G. uralensis were extracted with methanol
at room temperature as described previously [20]. It was
prepared by dissolving the material in absolute ethanol
to create a 1000 mg/ml stock. From the stock solution,
100 mg/ml, 200 mg/ml, and 400 mg/ml were made by
diluting the stock with autoclaved distilled water.Animals and experimental design
Colostrums-deprived piglets were obtained from sows
by hysterectomy. They were maintained in isolator units
as previously described using separate isolator units for
each treatment group [36]. Piglets were fed every 6
hours with a diet consisting of sterilized commercialized
milk. All piglets were negative for rotavirus antibodies
prior to RVA exposure. They were randomly divided into
eight groups: 1) virus-inoculated and mock-treated, 2)
virus-inoculated and 100 mg/ml of GUE treated, 3)
virus-inoculated and 200 mg/ml of GUE treated, 4)
virus-inoculated and 400 mg/ml of GUE treated, 5)
mock-inoculated and mock-treated, 6) mock-inoculated
and 100 mg/ml of GUE treated, 7) mock- inoculated and
200 mg/ml of GUE treated, and 8) mock-inoculated and
400 mg/ml of GUE treated. Each group contained three
piglets. At 3 days of age, piglets of groups 1-4 were or-
ally inoculated with 3 ml of the K85 strain containing a
virus titer of 5 x 105 FFU/ml. After DPI 2, piglets
showed signs of diarrhea. Among these groups, three
groups were treated four times daily with 100 mg/ml,
200 mg/ml, or 400 mg/ml of GUE for 7 days, respect-
ively. The remaining virus-inoculated group was mock-
treated. At 5 days of age, three mock-inoculated groups
were treated four times daily with 100 mg/ml, 200 mg/
ml, or 400 mg/ml GUE for 7 days, respectively. As the
control group, piglets were mock-inoculated and mock-
treated. The antiviral effects of GUE were evaluated on
the basis of diarrhea score, histopathological lesions in
the small intestines, quantitation of fecal virus shedding,
and expressions of different transcription factors and
cytokines. The results obtained from the groups treated
with GUE were compared with those of the mock-
inoculated and mock-treated groups. Piglets were also
observed for signs of adverse effects during drug admin-
istration. The studies performed were approved by the
University Animal Care Committee (CNU IACUC-YB-
R-2009-15).Evaluation of fecal consistency
Fecal consistency was examined daily after the inocula-
tion of K85 strain to evaluate the antiviral effect of GUE.
A 5-point rating system was used to evaluate fecal
consistency: 0, normal; 1, pasty; 2, semi-mucoid; 3, li-
quid; and 4, profuse diarrhea [37].Fecal specimens and extraction of viral dsRNA
Fecal samples were collected daily and were diluted 10
times with 0.01 M phosphate-buffered saline (PBS, pH
7.2). The suspensions were then vortexed for 30 s, cen-
trifuged (1200 x g for 20 min), and then the superna-
tants were collected and stored at -80°C until used. A
starting volume of 200 μl of centrifuged 10% fecal sus-
pensions was used for RNA extraction by an AccuPrepW
Viral RNA Extraction Kit (Bioneer, Daejeon, South
Korea) according to the manufacturer’s instructions.
Sample collection
All piglets were immediately necropsied after euthanasia
or death. The intestinal tracts were removed from the
abdominal cavities and the small and large intestinal
contents were collected at necropsy. Each part of small
and large intestines was sampled and fixed with 10%
buffered formalin solution. Serial 4 μm sections from
paraffin embedded blocks were stained with Mayer’s
hematoxyline and eosin, and examined microscopically.
In a blind fashion, histological evaluation was performed
on coded samples, and a comparison was made with the
sections from the mock-inoculated and mock-treated, or
virus-inoculated but mock-treated controls. Scoring for
the small intestinal changes were based on the average
villi/crypt (V/C) ratio plus the grade of epithelial cell
desquamation, which was measured as follows: V/C
ratio, 0 = normal; (V/C ≥6:1), 1 = mild; (V/C = 5.0 –
5.9:1), 2 = moderate; (V/C = 4.0 – 4.9:1), 3 = marked;
(V/C = 3.0 – 3.9:1), 4 = severe; (V/C ≤3.0:1), and des-
quamation grade, 0 = normal (no desquamation), 1 =
mild (a few desquamated cells of tip villous epithelium),
2 = moderate (desquamation of upper villous epithe-
lium), 3 = marked (desquamation of lower villous epi-
thelium), 4 = severe (desquamation of crypt epithelium).
Ten randomly selected villi and crypts on intestinal
histological sections were chosen to determine the
mean lesion changes similar to methods described
previously [24].
Real-time RT-PCR using SYBR Green chemistry
Using a primer pair specific to VP6 gene of RVA, a one-
step real-time RT-PCR assay based on SYBR Green de-
tection was carried out to quantify the RNA of RVA in
the fecal samples, as described previously [24]. Briefly,
total RNA extracted from each fecal sample was pro-
cessed using a Corbett Research Rotor-Gene Real-Time
Amplification System (Corbett Research, Mortlake, Aus-
tralia) and SensiMix one-step RT-PCR with SYBR Green
(Quantace, London, UK). The reaction mixture was
composed of 5 μl RNA, 12.5 μl SensiMix one-step mix-
ture, 1 μl each of 0.5 M forward and reverse primer, 0.5
μl of 50×SYBR Green solution, 0.5 μl of RNase inhibitor
(final concentration: 10 units), 0.5 μl of MgCl2 (final
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Reverse transcription was performed at 50°C for 30 min,
followed by 95°C for 15 min to activate the DNA poly-
merase and 45 three-step cycles: 95°C for 15 s, 51°C for
30 s, and 72°C for 1 min. Using the Rotagene 6000W, the
amount of RVA-specific RNA in the fecal samples was
quantified based on the standard curve derived from ser-
ial 10-fold dilutions of the in vitro transcription of com-
plementary RNA (cRNA). The highest amplification rate
was defined automatically in the initial exponential
phase. A direct relationship between the cycle number
and the log concentration of RNA molecules initially
present in the RT-PCR reaction was evident with regard
to the crossing points resulting from amplification
curves and this threshold. Rotogene 6000W software was
used to set up a standard curve that allowed the deter-
mination of concentration of RNA present in the sam-
ples using a linear regression analysis of the data.
Measurement of relative mRNA expression levels of p38,
c-Jun N-terminal kinase (JNK), nuclear factor-kappa B
(NFkB), interleukin (IL)8, IL10, interferon-beta (IFN-β), IFN-
γ and tumor necrosis factor-alpha (TNF-α) in spleen,
duodenum, jejunum, and ileum
Sample preparation of spleen and each part of small in-
testine for extracting total RNA was carried out as
described elsewhere [38,39]. Total RNA was extracted
using TriReagentW RNA Isolation Reagent (Molecular
Research Center, Cincinnati, OH, USA). Isolated RNA
was reverse transcribed using QuantiTectW Reverse
Transcription Kit (Qiagen, Valencia, CA, USA) accord-
ing to the manufacturer’s instructions. To reduce dis-
crepancies, all samples were transcribed concurrently in
reverse transcriptase efficiency. Real-time PCR primers
for porcine p38, JNK, NFκB, IL8, IL10, IFN-β, IFN-γ,
TNF-α and β-actin were designed as described elsewhere
[38]. mRNA expression levels of p38, JNK, NFκB, IL8,
IL10, IFN-β, IFN-γ and TNF-α were quantified by
real-time PCR assay using Rota-gene 6000W (Corbett
Research, Sydney, NSW, Australia) with 1 μg of cDNA.
Twenty-five μL real-time PCR reactions were carried out
using SensiMix one-step RT-PCR with SYBR Green
(Quantace, London, UK) according to manufactures
instructions. The qPCR conditions were performed as
described elsewhere [38]. The relative gene expression
was assessed by 2-2-ΔΔCt, where ΔCt = Ct of target
genes (NF-κB, IL8, IFN-β, TNF-α) - Ct of internal con-
trol gene (β-actin). ΔΔCt = ΔCt of samples for target
gene- ΔCt of the calibrator for the target gene.
Statistical analysis
The data gathered from this experiment were written as
mean ± standard deviation (SD). To compare between
groups, means of the different parameters were analyzedfor variance. In order to evaluate the significant differ-
ences between the groups, data was analyzed with
Tukey’s multiple comparison tests using Minitab Statis-
tical Software 13.20 (Minitab, State College, PA, USA),
and the level of significance was selected at p < 0.05.
Determinations of the One-way ANOVA polynomial or-
thogonal contrast for the pro-inflammatory markers
were performed using IBMW SPSSW Statistics Version
20.0 (Chicago, Illinois, USA).
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